The protective effect of influenza vaccination on the clinical course of coronary disease in patients with acute coronary syndromes treated by primary PCI - A report from FLUCAD study

Postepy w Kardiologii Interwencyjnej

Volumn 6, Issue 1, 2010, Pages 6-11

  Ciszewski, Andrzej ^a   Bilińska, Zofia T ^a   Kȩpka, Cezary ^a   Kruk, Mariusz ^a   Ksiȩzycka Majczyńska, Ewa ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Coronary artery disease; Influenza vaccination; Primary PCI

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 77951588050     PISSN: 17349338     EISSN: None     Source Type: Journal    
DOI: 10.5114/pwki.2010.13820     Document Type: Article

References (13)

1. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Eng J Med 1976; 295: 369-377.
2. Kol A, Libby P. Molecular mediators of arterial inflammation: role of microbal products? Am Heart J 1999; 138: S450-S452.
3. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101: 512-513.
4. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-482.
5. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease: results from 8 years of autopsies in 34 892 subjects. Eur Heart J 2007; 28: 1205-1210. (Pubitemid 47343835)
6. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039-3045.
7. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513-518. Erratum in: Stroke 2002; 33: 1171. (Pubitemid 34123398)
8. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674-677.
9. Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002; 105: 2143-2147. (Pubitemid 34517156)
10. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in acute prevention from coronary ischemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008; 29: 1350-1358. (Pubitemid 351806477)
11. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Eng J Med 2004; 351: 2611-2618. (Pubitemid 39628582)
12. Van de Werf F, Bax J, Betriu A, et al. ESC Guidelines. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.
13. Gurevich VS. Influenza, autoimmunity and atherosclerosis. Autoimmun Rev 2005; 4: 101-105.